Exploring the effect of maternal autoimmune diseases on behavioral and social difficulties risk in children born preterm: evidence from EPIPAGE-2 study
Abstract
Maternal immune activation (MIA) and preterm birth have both been associated with increased risk of autism spectrum disorder but their combined impact in preterm children is unclear. This prospective population-based cohort study used data from the French EPIPAGE-2 study, which included liveborn infants delivered at 22 to 34 weeks’ gestation in 2011 and followed them to 5 years of age. Neurodevelopmental outcomes at 2 years’ corrected age and at 5 years were assessed. Among 3609 children (155 [4.3%] exposed), maternal autoimmune diseases were initially associated with more impaired personal-social skills on the Ages & Stages Questionnaire at 2 years and a lower prevalence of high Social Communication Questionnaire scores at 5 years, but these associations were no longer statistically significant after adjustment. No significant associations were found between maternal autoimmune diseases and global developmental delay, ASD risk, or behavioral difficulties at 2 or 5 years in adjusted analyses. Subgroup analyses by gestational age and by exposure to immunosuppressive therapy also showed no increased risk. In this national preterm birth cohort, maternal autoimmune diseases during pregnancy were not associated with increased early behavioral or social communication difficulties in offspring. However, given the small number of exposed children, the predominance of endocrine autoimmune diseases, and the lack of immune activation biomarkers, these findings should be interpreted cautiously and warrant confirmation in larger, mechanistically informed studies
Related
- Functional and dysfunctional T regulatory cell states in human tissues in RA and other autoimmune arthritic diseases
- MAKAAO, an open access resource linking human autoantibodies and autoimmune diseases
- Exploring psychometric properties of the Strengths and Difficulties Questionnaire (SDQ) among adolescent Palestinian refugee girls in Palestine and Jordan
- Epigenomic insights into CD4+ T-cell–mediated pathogenesis in autoimmune diseases
- Rituximab-induced hypogammaglobulinemia in autoimmune cytopenia and associated diseases.
BibTeX
@article{ellul2026exploring,
title = {{Exploring the effect of maternal autoimmune diseases on behavioral and social difficulties risk in children born preterm: evidence from EPIPAGE-2 study}},
author = {Pierre Ellul and Laetitia Marchand-Martin and Fanny Salmon and Pierre-Yves Ancel and Véronique Pierrat and Mathilde Letouzey},
journal = {Translational Psychiatry},
year = {2026},
month = oct,
doi = {10.1038/s41398-026-04534-0},
url = {https://www.nature.com/articles/s41398-026-04534-0},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Exploring the effect of maternal autoimmune diseases on behavioral and social difficulties risk in children born preterm: evidence from EPIPAGE-2 study
AU - Pierre Ellul
AU - Laetitia Marchand-Martin
AU - Fanny Salmon
AU - Pierre-Yves Ancel
AU - Véronique Pierrat
AU - Mathilde Letouzey
PY - 2026
DA - 2026/10/21
JO - Translational Psychiatry
DO - 10.1038/s41398-026-04534-0
UR - https://www.nature.com/articles/s41398-026-04534-0
AB - Maternal immune activation (MIA) and preterm birth have both been associated with increased risk of autism spectrum disorder but their combined impact in preterm children is unclear. This prospective population-based cohort study used data from the French EPIPAGE-2 study, which included liveborn infants delivered at 22 to 34 weeks’ gestation in 2011 and followed them to 5 years of age. Neurodevelopmental outcomes at 2 years’ corrected age and at 5 years were assessed. Among 3609 children (155 [4.3%] exposed), maternal autoimmune diseases were initially associated with more impaired personal-social skills on the Ages & Stages Questionnaire at 2 years and a lower prevalence of high Social Communication Questionnaire scores at 5 years, but these associations were no longer statistically significant after adjustment. No significant associations were found between maternal autoimmune diseases and global developmental delay, ASD risk, or behavioral difficulties at 2 or 5 years in adjusted analyses. Subgroup analyses by gestational age and by exposure to immunosuppressive therapy also showed no increased risk. In this national preterm birth cohort, maternal autoimmune diseases during pregnancy were not associated with increased early behavioral or social communication difficulties in offspring. However, given the small number of exposed children, the predominance of endocrine autoimmune diseases, and the lack of immune activation biomarkers, these findings should be interpreted cautiously and warrant confirmation in larger, mechanistically informed studies
SN - 2158-3188
ER -